Published in World J Gastroenterol on August 14, 2010
Precision prevention of oesophageal adenocarcinoma. Nat Rev Gastroenterol Hepatol (2015) 0.88
The impact of laparoscopic anti-reflux surgery in patients with Barrett's esophagus. Surg Endosc (2014) 0.80
Diagnosis and management of Barrett's esophagus. Surg Clin North Am (2012) 0.78
Gastroesophageal reflux disease: From heartburn to cancer. World J Gastroenterol (2010) 0.77
Anti-reflux surgery does not remove cancer risk in Barrett's esophagus. Surg Endosc (2011) 0.76
Updated guidelines 2008 for the diagnosis, surveillance and therapy of Barrett's esophagus. Am J Gastroenterol (2008) 7.94
Barrett's esophagus. Gastroenterology (2002) 3.27
Clinical practice. Barrett's Esophagus. N Engl J Med (2002) 2.99
Clinical practice. Barrett's esophagus. N Engl J Med (2009) 2.83
Targeting cyclooxygenase-2 in human neoplasia: rationale and promise. Cancer Cell (2003) 2.71
Non-steroidal anti-inflammatory drugs and risk of neoplastic progression in Barrett's oesophagus: a prospective study. Lancet Oncol (2005) 2.40
Barrett's esophagus can and does regress after antireflux surgery: a study of prevalence and predictive features. J Am Coll Surg (2003) 2.36
Is esophageal adenocarcinoma occurring late after antireflux surgery due to persistent postoperative reflux? World J Surg (2007) 2.07
New British Society of Gastroenterology (BSG) guidelines for the diagnosis and management of Barrett's oesophagus. Gut (2006) 2.07
Statins inhibit proliferation and induce apoptosis in Barrett's esophageal adenocarcinoma cells. Am J Gastroenterol (2008) 2.03
Long-term results of a randomized prospective study comparing medical and surgical treatment of Barrett's esophagus. Ann Surg (2003) 2.03
Proton-pump inhibitor therapy and the development of dysplasia in patients with Barrett's oesophagus. Med J Aust (2004) 1.97
Abdominal obesity and the risk of esophageal and gastric cardia carcinomas. Cancer Epidemiol Biomarkers Prev (2008) 1.89
Continuous treatment of Barrett's oesophagus patients with proton pump inhibitors up to 13 years: observations on regression and cancer incidence. Aliment Pharmacol Ther (2006) 1.74
Secondary chemoprevention of Barrett's esophagus with celecoxib: results of a randomized trial. J Natl Cancer Inst (2007) 1.65
Barrett's epithelium after antireflux surgery. J Gastrointest Surg (2005) 1.52
Medications (NSAIDs, statins, proton pump inhibitors) and the risk of esophageal adenocarcinoma in patients with Barrett's esophagus. Gastroenterology (2010) 1.51
Long-term outcome of antireflux surgery in patients with Barrett's esophagus. Ann Surg (2001) 1.48
Late results of the surgical treatment of 125 patients with short-segment Barrett esophagus. Arch Surg (2009) 1.44
Clinical and histologic follow-up after antireflux surgery for Barrett's esophagus. J Gastrointest Surg (2002) 1.31
Medication usage and the risk of neoplasia in patients with Barrett's esophagus. Clin Gastroenterol Hepatol (2009) 1.29
Hormone replacement therapy and risks of oesophageal and gastric adenocarcinomas. Br J Cancer (2006) 1.16
Chemoprevention of oesophageal cancer and the AspECT trial. Recent Results Cancer Res (2009) 1.13
Efficacy of Nissen fundoplication versus medical therapy in the regression of low-grade dysplasia in patients with Barrett esophagus: a prospective study. Ann Surg (2006) 1.12
Clinical and pathologic response of Barrett's esophagus to laparoscopic antireflux surgery. Ann Surg (2003) 1.08
Normalization of intestinal metaplasia in the esophagus and esophagogastric junction: incidence and clinical data. Am J Gastroenterol (2007) 0.99
Aberrant arachidonic acid metabolism in esophageal adenocarcinogenesis, and the effects of sulindac, nordihydroguaiaretic acid, and alpha-difluoromethylornithine on tumorigenesis in a rat surgical model. Carcinogenesis (2002) 0.96
Long-term clinical and pathologic response of Barrett's esophagus after antireflux surgery. Am J Surg (2004) 0.94
Management of nondysplastic Barrett's esophagus: where are we now? Am J Gastroenterol (2009) 0.94
Clinical and endoscopic factors predict higher pathologic grades of Barrett dysplasia. Cancer (2007) 0.90
The effect of oral administration of ursodeoxycholic acid and high-dose proton pump inhibitors on the histology of Barrett's esophagus. Dis Esophagus (2008) 0.89
Aspirin is not chemoprotective for Barrett's adenocarcinoma of the oesophagus in multicentre cohort. Eur J Cancer Prev (2009) 0.86
Efficacy of laparoscopic antireflux surgery in patients with Barrett's esophagus. Am J Surg (2003) 0.82
Treatment modality and risk of development of dysplasia and adenocarcinoma in columnar-lined esophagus. Dis Esophagus (2008) 0.82
Histologic and clinical outcome after laparoscopic Nissen fundoplication for gastroesophageal reflux disease and Barrett's esophagus. Surg Endosc (2005) 0.81
Effect of n-3 polyunsaturated fatty acids on Barrett's epithelium in the human lower esophagus. Am J Clin Nutr (2008) 0.81
Barrett's esophagus: diagnostic challenges and recent developments. Ann Diagn Pathol (2009) 0.81
Impact of antireflux operation on columnar-lined esophagus. J Am Coll Surg (2003) 0.80
Barrett's esophagus: the role of laparoscopic fundoplication. Ann Thorac Surg (2004) 0.80
Chemoprevention of adenocarcinoma associated with Barrett's esophagus: potential options. Dig Dis (2009) 0.79
Adenocarcinoma appearing very late after antireflux surgery for Barrett's esophagus: long-term follow-up, review of the literature, and addition of six patients. J Gastrointest Surg (2004) 0.77
Laparoscopic treatment of Barrett's esophagus: long-term results. Surg Endosc (2006) 0.77
Esophageal sphincter device for gastroesophageal reflux disease. N Engl J Med (2013) 5.41
Imaging of subsquamous Barrett's epithelium with ultrahigh-resolution optical coherence tomography: a histologic correlation study. Gastrointest Endosc (2009) 1.92
Characterization of a recurrent germ line mutation of the E-cadherin gene: implications for genetic testing and clinical management. Clin Cancer Res (2005) 1.46
Complications of PTFE mesh at the diaphragmatic hiatus. J Gastrointest Surg (2007) 1.22
Long-term outcome of esophagectomy for high-grade dysplasia or cancer found during surveillance for Barrett's esophagus. J Gastrointest Surg (2006) 1.05
Histologic features of reflux-attributed laryngeal lesions. Am J Med (2003) 1.00
Achalasia. Surg Clin North Am (2005) 0.99
Laparoscopic repair of paraesophageal hernia. Surg Clin North Am (2005) 0.98
Return of esophageal function after treatment for achalasia as determined by impedance-manometry. J Gastrointest Surg (2007) 0.94
Variation in esophagectomy outcomes in hospitals meeting Leapfrog volume outcome standards. Ann Thorac Surg (2011) 0.94
The safety of biologic mesh for laparoscopic repair of large, complicated hiatal hernia. Surg Endosc (2011) 0.93
Surgical management of esophageal motility disorders. J Surg Res (2004) 0.92
Laparoscopic splenopexy for wandering spleen: case report and review of the literature. Surg Laparosc Endosc Percutan Tech (2010) 0.91
Recurrent dysphagia after Heller myotomy: is esophagectomy always the answer? J Am Coll Surg (2013) 0.89
Laparoscopic sleeve gastrectomy: an alternative for recurrent paraesophageal hernias in obese patients. JSLS (2006) 0.88
Laparoscopy as the initial approach for epiphrenic diverticula. Surg Endosc (2011) 0.87
Pulmonary function in the morbidly obese. Surg Obes Relat Dis (2008) 0.84
High-resolution manometry in evaluation of factors responsible for fundoplication failure. J Am Coll Surg (2010) 0.84
Comprehensive evaluation of endoscopic fundoplication using the EsophyX™ device. Surg Endosc (2011) 0.83
Laparoscopic Heller myotomy and Roux-en-Y gastric bypass: a novel operation for the obese patient with achalasia. J Laparoendosc Adv Surg Tech A (2005) 0.82
Single-incision laparoscopy: training, techniques, and safe introduction to clinical practice. J Laparoendosc Adv Surg Tech A (2011) 0.81
Improvement of respiratory symptoms following Heller myotomy for achalasia. J Gastrointest Surg (2010) 0.79
Assessment of a simple, novel endoluminal method for gastrotomy closure in NOTES. Surg Endosc (2011) 0.79
Treatment of Achalasia. Curr Treat Options Gastroenterol (2005) 0.78
Pseudoachalasia caused by retroperitoneal B-cell lymphoma. Clin Gastroenterol Hepatol (2008) 0.76
Laparoscopic treatment of Barrett's esophagus*. Dis Mon (2004) 0.76
Video. Laparoscopic repair of congenital bilateral Morgagni hernia. Surg Endosc (2011) 0.76
Gastric mass. MedGenMed (2005) 0.75
Proximal Roux-en-Y gastric bypass alters drug absorption pattern but not systemic exposure of CYP3A4 and P-glycoprotein substrates. Pharmacotherapy (2015) 0.75
Laparoscopic Roux-en-Y gastric bypass for morbid obesity. MedGenMed (2006) 0.75
Cases in videoendoscopic surgery from the University of Washington School of Medicine. Surgical management of esophageal epiphrenic diverticula. MedGenMed (2004) 0.75
Outcomes of laparoscopic Nissen fundoplication in patients with the "hypercontractile esophagus". Arch Surg (2002) 0.75
Laparoscopic paraesophageal hernia repair. Surg Laparosc Endosc Percutan Tech (2013) 0.75
Laparoscopic paraesophageal hernia repair. Adv Surg (2007) 0.75
Prevention of leaks in esophageal surgery. J Gastrointest Surg (2011) 0.75
Are laparoscopic antireflux procedures useful? Nat Clin Pract Gastroenterol Hepatol (2005) 0.75
Evaluation and treatment of laryngopharyngeal reflux symptoms. Thorac Surg Clin (2011) 0.75